Add Company
Join Now

GO Therapeutics Revenue and Competitors

License our Company Data API

Natick, MA USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • GO Therapeutics's estimated annual revenue is currently $1.7M per year.(i)
  • GO Therapeutics's estimated revenue per employee is $155,000

Employee Data

  • GO Therapeutics has 11 Employees.(i)
  • GO Therapeutics grew their employee count by 0% last year.

GO Therapeutics's People

NameTitleEmail/Phone
1
CEO and co-founderReveal Email/Phone
2
Co-FounderReveal Email/Phone
3
Senior DirectorReveal Email/Phone
4
ScientistReveal Email/Phone
5
Senior ScientistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$12.7M82-45%$107.3MN/A
#2
$0.2M1-50%N/AN/A
#3
$6.2M4021%N/AN/A
#4
$42.2M2184%$165MN/A
#5
$14.6M94-37%$312.8MN/A
#6
$0.3M2-67%N/AN/A
#7
$235M366-5%$340.9MN/A
#8
$56M289-7%$7.6MN/A
#9
$4.7M6136%N/AN/A
#10
$2M138%N/AN/A
Add Company

What Is GO Therapeutics?

GO Therapeutics is exploiting unique aspects of cancer cell biology to develop a new class of cancer therapies for previously intractable solid tumors. We target O-linked glycoproteins specific to cancer cells to develop proprietary, high-affinity antibodies to novel cancer-specific targets. Our antibodies are the basis for a broad array of potent cancer-killing modalities including T-cell bispecifics (TCBs), CAR-T, and antibody drug conjugates (ADCs). Each are designed to kill cancer while sparing healthy tissue.

keywords:N/A

N/A

Total Funding

11

Number of Employees

$1.7M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1M1157%N/A
#2
$1M120%N/A
#3
$2.3M14-18%N/A
#4
$1.2M14-7%N/A
#5
$2.3M1515%N/A